ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Santhera Pharmaceuticals Holding Ag

Santhera Pharmaceuticals Holding Ag (0QN1)

190.20
0.00
(0.00%)
終了 1月21日 1:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
190.20
買値
0.00
売値
0.00
出来高
4,911
0.00 日の範囲 0.00
190.20 52 週間の範囲 190.20
時価総額
前日終値
190.20
始値
-
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
852
発行済株式数
11,315,000
配当利回り
-
PER
1.95
1 株当たり利益 (EPS)
4.84
歳入
103.41M
純利益
54.78M

Santhera Pharmaceuticals Holding Ag について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Liestal, Che
設立
-
Santhera Pharmaceuticals Holding Ag is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker 0QN1. The last closing price for Santhera Pharmaceuticals was CHF190.20. Over the last year, Santhera Pharmaceuticals shares have traded in a share price range of CHF 190.20 to CHF 190.20.

Santhera Pharmaceuticals currently has 11,315,000 shares in issue. The market capitalisation of Santhera Pharmaceuticals is CHF2.15 billion. Santhera Pharmaceuticals has a price to earnings ratio (PE ratio) of 1.95.

0QN1 最新ニュース

Santhera publiziert Zeitplan für die Aktienzusammenlegung

Santhera publiziert Zeitplan für die Aktienzusammenlegung NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...

Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Shareholders Approve all Board Proposals at Today’s Annual General Meeting Pratteln, Switzerland, June 27, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved...

Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren

Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren Ad-hoc-Mitteilung...

Santhera Publishes Agenda for its Annual General Meeting

Santhera Publishes Agenda for its Annual General Meeting NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...

Santhera veröffentlicht Jahresbericht 2022

Santhera veröffentlicht Jahresbericht 2022 Ad-hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 31. Mai 2023 – Santhera Pharmaceuticals (SIX: SANN) gibt die Veröffentlichung des...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
100190.2190.2190.22218190.2DE
400190.2190.2190.21535190.2DE
1200190.2190.2190.2852190.2DE
2600190.2190.2190.2499190.2DE
5200190.2190.2190.2451190.2DE
15600190.2190.2190.21867190.2DE
26000190.2190.2190.21753190.2DE

0QN1 - Frequently Asked Questions (FAQ)

What is the current Santhera Pharmaceuticals share price?
The current share price of Santhera Pharmaceuticals is CHF 190.20
How many Santhera Pharmaceuticals shares are in issue?
Santhera Pharmaceuticals has 11,315,000 shares in issue
What is the market cap of Santhera Pharmaceuticals?
The market capitalisation of Santhera Pharmaceuticals is CHF 2.15B
What is the 1 year trading range for Santhera Pharmaceuticals share price?
Santhera Pharmaceuticals has traded in the range of CHF 190.20 to CHF 190.20 during the past year
What is the PE ratio of Santhera Pharmaceuticals?
The price to earnings ratio of Santhera Pharmaceuticals is 1.95
What is the cash to sales ratio of Santhera Pharmaceuticals?
The cash to sales ratio of Santhera Pharmaceuticals is 1.03
What is the reporting currency for Santhera Pharmaceuticals?
Santhera Pharmaceuticals reports financial results in CHF
What is the latest annual turnover for Santhera Pharmaceuticals?
The latest annual turnover of Santhera Pharmaceuticals is CHF 103.41M
What is the latest annual profit for Santhera Pharmaceuticals?
The latest annual profit of Santhera Pharmaceuticals is CHF 54.78M
What is the registered address of Santhera Pharmaceuticals?
The registered address for Santhera Pharmaceuticals is HAMMERSTRASSE 49, LIESTAL, 4410
What is the Santhera Pharmaceuticals website address?
The website address for Santhera Pharmaceuticals is www.santhera.com
Which industry sector does Santhera Pharmaceuticals operate in?
Santhera Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WSLWorldsec Ld
2.00p
(60.00%)
105.37k
BLUBlue Star Capital Plc
12.00p
(45.45%)
1.54M
NTQEnteq Technologies Plc
1.40p
(40.00%)
19.81M
BANKFiinu Plc
10.25p
(36.67%)
12.95M
TIRTiger Royalties And Investments Plc
0.16p
(28.00%)
139.07M
PODPPod Point Group Holdings Plc
10.88p
(-35.20%)
6.83M
PALMPanther Metals Plc
53.50p
(-35.15%)
226.06k
NOGNostrum Oil & Gas Plc
2.51p
(-23.82%)
117.6k
ADMEAdm Energy Plc
0.175p
(-22.22%)
1.19M
PRDPredator Oil & Gas Holdings Plc
5.85p
(-20.95%)
5.72M
NTVONativo Resources Plc
0.0021p
(10.53%)
844.9M
TRPTower Resources Plc
0.0305p
(-1.61%)
507.22M
PREMPremier African Minerals Limited
0.027p
(-3.57%)
504.81M
SYMESupply@me Capital Plc
0.003p
(-13.04%)
461.39M
ORCPOracle Power Plc
0.016p
(-5.88%)
308.68M

最近閲覧した銘柄

Delayed Upgrade Clock